pharma · Acute Ischemic Stroke · Chronic Kidney Disease · DMAC
DiaMedica Therapeutics
DiaMedica Therapeutics is a pharma organization headquartered in Minneapolis, USA. It trades on NYSE under ticker DMAC. Primary therapeutic focus areas include Acute Ischemic Stroke, Chronic Kidney Disease, Diabetes Type
Company details
- Status
- Public
- HQ
- Minneapolis, USA
- Employees
- 45
- Programs
- 8
- Drugs
- 7
- Patents
- 9
Quick answer
DiaMedica Therapeutics is a pharma organization headquartered in Minneapolis, USA. It trades on NYSE under ticker DMAC. Primary therapeutic focus areas include Acute Ischemic Stroke, Chronic Kidney Disease, Diabetes Type 2, Kidney Diseases, Pre-Eclampsia. NovaPharmaNews links 8 clinical program(s), 0 drug profile(s), and 9 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 2 (3), phase 3 (2), phase 1 (2).
Company snapshot
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), is a clinical-stage biopharmaceutical company that is focused on developing novel treatments where there is significant unmet clinical need or where no current therapies are available, with a focus on preeclampsia and acute ischemic stroke. For more information please visit www.diamedica.com.
- 8 active pipeline program(s) linked via ClinicalTrials.gov.
- 9 US patent(s) indexed to this assignee profile.
- 8 trial update(s) in the last 12 months.
Public regulatory, clinical, patent, and corporate records for DiaMedica Therapeutics. Not investment advice.
Top assets
Lead pipeline drugs
- approved
- Marketed / approved
- Marketed / approved
- approved
Active clinical programs
- Phase 3
- Phase 3
- Phase 2
- Phase 2
Momentum
Proprietary activity score for DiaMedica Therapeutics.
1 active signal
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Competitor landscape
Therapeutic-area overlap peers from registry and pipeline signals.
- Peer + 0 momentum
Recent activity
Latest pipeline, patent, and corporate events for DiaMedica Therapeutics.
- Clinical update
- Clinical update
- Clinical update
- Clinical update
- Clinical update
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is DiaMedica Therapeutics?
-
Is DiaMedica Therapeutics publicly traded?
-
What drugs does DiaMedica Therapeutics develop or market?
-
What are the latest developments for DiaMedica Therapeutics?
-
What therapeutic areas does DiaMedica Therapeutics focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.